{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:38:09Z","timestamp":1759624689037,"version":"build-2065373602"},"reference-count":4,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.eururo.2020.11.037","type":"journal-article","created":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T09:01:55Z","timestamp":1606467715000},"page":"431-432","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Re: Systemic Therapy for Bladder Pain Syndrome\/Interstitial Cystitis (BPS\/IC): Systematic Review of Published Trials in the Last 5 Years"],"prefix":"10.1016","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0665-3486","authenticated-orcid":false,"given":"Karl-Erik","family":"Andersson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2020.11.037_bib0005","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.urology.2014.02.050","article-title":"Efficacy of daily low-dose sildenafil for treating interstitial cystitis: results of a randomized, double-blind, placebo-controlled trial\u2014treatment of interstitial cystitis\/painful bladder syndrome with low-dose sildenafil","volume":"84","author":"Chen","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2020.11.037_bib0010","doi-asserted-by":"crossref","first-page":"235","DOI":"10.5213\/inj.1735022.511","article-title":"Current pharmacologic approaches in painful bladder research: an update","volume":"21","author":"Andersson","year":"2017","journal-title":"Int Neurourol J"},{"key":"10.1016\/j.eururo.2020.11.037_bib0015","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.eururo.2018.07.026","article-title":"A randomized, double-blind, placebo-controlled trial of certolizumab pegol in women with refractory interstitial cystitis\/bladder pain syndrome","volume":"74","author":"Bosch","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2020.11.037_bib0020","series-title":"Proceedings of the 45th International Continence Society Annual Meeting, October 6\u20139, 2015, Montreal, Canada","article-title":"A phase 2 study in women with interstitial cystitis\/bladder pain syndrome (IC\/BPS) of the novel P2X3 antagonist AF-219","author":"Moldwin","year":"2015"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283820309386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283820309386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T13:07:41Z","timestamp":1759583261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283820309386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":4,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0302283820309386"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2020.11.037","relation":{},"ISSN":["0302-2838"],"issn-type":[{"type":"print","value":"0302-2838"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Re: Systemic Therapy for Bladder Pain Syndrome\/Interstitial Cystitis (BPS\/IC): Systematic Review of Published Trials in the Last 5 Years","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2020.11.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}